Bizarre Patents
Mountable Printable Placard With Headband
A resilient headband in a shape for being mounted on the head of the user. The headband is equipped with a longitudinal slotted member for holding a placard.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8071794 | Long wavelength thiol-reactive fluorophores Reactive fluorescent dyes compositions and methods of using same are disclosed. Squaraine nucleus, Nile Red nucleus, benzodioxazole nucleus, coumarin nucleus or aza coumarin nucleus dyes are disclosed having thiol-reactive groups. Squaraine nucleus, Nile Red nucleus... | 12/06/2011 |
| 7897792 | Coumarin derivative having antitumor activity The present invention provides a compound represented by general formula (1) below or a pharmaceutically acceptable salt thereof: wherein: X is selected from heteroaryl etc., Y1 and Y2 are selected fro... | 03/01/2011 |
| 7709664 | Coumarin derivatives useful as TNFα inhibitors Novel compounds composition capable of inhibiting TNFα and having anti immunoinflammatory and autoimmune properties useful in a pharmaceutical composition, such as for a drug containing this as an active ingredient; and a therapeutic method with the use of these no... | 05/04/2010 |
| 7507837 | Process for performing an isolated Pd(II)-mediated oxidation reaction There is disclosed a process for performing an isolated Pd(II) mediated oxidation reaction electrochemically. The inventive process is performed on an electrode array device having a plurality of separately addressable electrodes. Preferably, the Pd(II) mediated oxi... | 03/24/2009 |
| 7439265 | Irciniastatins a and b The Indo-Pacific marine sponge Ircinia ramosa has been found to contain two powerful (GI50 0.001 to | 10/21/2008 |
| 7435455 | Dihydrocoumarin derivative, liquid crystal composition containing the same, and liquid crystal display device A dihydrocoumarin ring-containing compound of the invention is represented by the following formula (1): wherein R represents hydrogen or an alkyl; A1 to A3 each represents 1,4-cyclohexylene or 1,4-phe... | 10/14/2008 |
| 7304168 | Photo-caged fluorescent molecules A class of photo-caged and cell permeable fluorescent molecules having high uncaging cross sections, robust fluorescence enhancement, and flexible chemistry for bioconjugation. Some of the photo-caged fluorescent molecules are derived from 6-chloro-7-hydroxy-coumari... | 12/04/2007 |
| 7282575 | Functional peptide nucleic acid monomer and process for producing the same A compound represented by the general formula (I) below: In the formula, A is as defined in the specification and B denotes where n is an integer of 1 to 4, ... | 10/16/2007 |
| 7259185 | Stable warfarin sodium liquid formulation and method of making same A stable liquid composition comprising warfarin sodium, glycerin, an alcohol such as ethanol, and a pH buffer such as a phosphate buffer providing a pH above 7 is provided. The stability of the composition is characterized by the amount of warfarin sodium in the com... | 08/21/2007 |
| 7259265 | Coumarin compounds and method for preparing and using the same 4-Substituted coumarin compounds having the general formula of where R is H, CHO, OCH3, X, NO2, an alkyl having C1-10, —OCH2O—, an aryl being mono- or poly-substitu... | 08/21/2007 |
| 7226945 | Estrogen receptor-β ligands A method for treating a disease associated with the estrogen receptor-β, comprising the step of administiering a therapeutically-effective amount of a compound that satifies the equation: KiαA/KiβA>25, optionally having general structure (I)... | 06/05/2007 |
| 7094378 | Method and apparatus for inactivation of biological contaminants using photosensitizers Methods and apparatuses for treating fluids to inactivate microorganisms which may be present therein, said fluid containing one or more components selected from the group consisting of protein, blood and blood constituents are provided. The methods comprise adjusti... | 08/22/2006 |
| 7064207 | Androgen receptor antagonists The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor. ... | 06/20/2006 |
| 7057048 | Androgen receptor antagonists The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor. ... | 06/06/2006 |
| 7026491 | Coumarin derivatives useful as TNFα inhibitors Novel compounds composition capable of inhibiting TNFα and having antiimmunoinflammatory and autoimmune properties useful in a pharmaceutical composition, such as for a drug containing this as an active ingredient; and a therapeutic method with the use of these nov... | 04/11/2006 |
| 6900340 | Preparation of isocoumarin derivatives and intermediates for the synthesis thereof A method of preparing optically active isocoumarin-3-yl-acetic acid derivatives represented by Formula (I): wherein a specific isocoumarin-ketene derivative is subjected to an addition reaction with an optically active... | 05/31/2005 |
| 6900239 | Tumor chemopotentiation using isocoumarin derivatives A method for enhancing the efficacy of chemotherapy in the treatment of cancer in animals, particularly humans, is provided wherein isocoumarin derivatives that exhibit unique chemopotentiation properties are employed in a combination treatment with chemotherapy. | 05/31/2005 |
| 6800768 | Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents Novel coumarin derivatives comprising a coumarin moiety linked to a non-nucleosidic backbone moiety are disclosed. The resulting molecules are typically used as photoactivate crosslinking groups when incorporated into polynucleotides as replacements for one or more ... | 10/05/2004 |
| 6770764 | Trypsin substrate and diagnostic device, and method of using same A compound of the formula (I) wherein R1 is a protecting group for Nα, R2 is a protecting group for NG, and R3 is aryl, and wherein the compound of formula (I) is a trypsin su... | 08/03/2004 |
| 6752862 | Color fading/discoloration preventive agent Disclosed are a color fading/discoloration preventive agent containing as its active ingredient a coumarin analog represented by general formula (1) below, a glycoside of that analog, or a plant extract containing the coumarin analog or its glycoside: | 06/22/2004 |
| 6734313 | Synthesis of spiro esters, spiro ortho carbonates, and intermediates Ortho esters and ortho carbonates can be produced by alkylating esters and carbonates with, for example, the hexafluorophosphate salt of a trialkyl oxonium ion. The spiro species are useful intermediates in the synthesis of complex organic molecules. Synthetic pathw... | 05/11/2004 |
| 6716996 | Process for preparing substituted coumarins The present invention relates to a process for preparing substituted coumarins. More particularly, the present invention relates to a process for preparing substituted coumarins using polyaniline salts as catalysts. ... | 04/06/2004 |
| 6670383 | Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity The present invention relates to compounds and compositions useful in treating or preventing conditions and diseases related to Mycobacterium infection, and methods of use directed thereto.... | 12/30/2003 |
| 6617124 | 7-alkoxycoumarins as cytochrome p450 substrates Coumarin derivatives as substrates for cytochrome P450 enzyme.... | 09/09/2003 |
| 6613918 | Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates Ortho esters and ortho carbonates can be produced by alkylating esters and carbonates with, for example, the hexafluorophosphate salt of a trialkyl oxonium ion. The spiro species are useful intermediates in the synthesis of complex organic molecules. Synt... | 09/02/2003 |
| 6538022 | Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors) This invention relates to determining the three-dimensional structure of the cytosolic domain of phospholamban (PLB) and its active site from NMR data of sufficiently high resolution for the three-dimensional structure determination. The invention also re... | 03/25/2003 |
| 6455579 | Pyran derivatives Disclosed are pyran derivatives, which have distinctive sensitivity to visible light and distinctive luminous ability. The derivatives are useful in photopolymerization, electroluminescence, and dye lasers, and are obtainable through a step of reacting a ... | 09/24/2002 |
| 6426420 | Process for producing isocoumarines and intermediates for the same Provided is a process for producing an isocoumarin-3-yl-acetic acid derivative, characterized by reacting a homophthalic acid derivative represented by a formula: ##STR1## (wherein Rc, R2 and R are mainly protecting groups) with a ... | 07/30/2002 |
| 6420130 | Optical molecular sensors for cytochrome P450 activity The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods. The optical probe... | 07/16/2002 |
| 6420401 | 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives Substituted derivatives of 1,2,5-thiadiazolidin-3-one 1,1-dioxides, oligomers containing them, and methods of using them.... | 07/16/2002 |
| 6387258 | Method of purifying statins from a fermentation broth A process for purifying statin compounds from a fermentation broth by extraction and crystallization is disclosed. A fermentation broth is subjected to a pretreatment procedure which involves an alkaline pretreatment and an alkaline purification. Followin... | 05/14/2002 |
| 6372739 | Compounds and methods for modulation of estrogen receptors Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same: ##STR1## wherein R1, R2, R3, n and p are ... | 04/16/2002 |
| 6344330 | Pharmacophore recombination for the identification of small molecule drug lead compounds The present invention is directed to novel methods for identifying small molecule ligands that are capable of binding with high affinity to a biological target molecule of interest. High affinity binding ligands identified by the described methods find us... | 02/05/2002 |
| 6344334 | Pharmacophore recombination for the identification of small molecule drug lead compounds Method for identifying a drug lead compound that inhibits binding of target bioogical molecules (TBM) by contacting TBM with members of a library of candidate cross-linked target binding fragments (CXBF), each CXBF having at least two candidate target bin... | 02/05/2002 |
| 6331562 | Compounds and methods for modulation of estrogen receptors Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same: ##STR1## wherein R1, R2, R3, n and p are ... | 12/18/2001 |
| 6310248 | Process and intermediates The invention relates to a process for the enantioselective preparation of tolterodine and analogues and salts thereof comprises the steps of: a) enantioselectively reducing the carbonyl function in a compound of formula (II): ##STR1## wherein R1 | 10/30/2001 |
| 6291456 | Compounds and methods for modulation of estrogen receptors Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same: ##STR1## wherein R1, R2, R3, n and p are ... | 09/18/2001 |
| 6258839 | Isolation of naturally occuring isoflavanone and some clinical uses thereof A compound of general formula I ##STR1## in which the 2-3 bond in ring C could be double or single bond. Ring B and its substituents may be attached at position 2 (at J) in ring C. The key feature in the modifications is that the prenylation must not cycl... | 07/10/2001 |
| 6215006 | Process for the preparation of 3-isochromanoes by cyclization of o-chloromethylphenylacetic acids The present invention relates to a process for the preparation of a 3-isochromanone of the formula (I) ##STR1## by reaction of an o-chloromethylphenylacetic acid of the formula (II) ##STR2## at a temperature of 100 to 250° C. in the presence or absence o... | 04/10/2001 |
| 6100292 | Ketone derivatives and their medical applications This invention relates to ketones represented by the following formula ##STR1## and to drugs in which such a ketone or pharmacologically acceptable salt thereof is an effective component. The ketones of the present invention encourage the production of pl... | 08/08/2000 |
